In an interview, Dr. Apoorv Shanker with Chemical Today Magazine delves into the use of polymers and sift materials in his research on cancer immunotherapy.
Dr. Shanker is a post-doctoral associate at Prof. Paula T. Hammond Lab, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT).
Research insight.
With new cancer treatment regimens coming up, a lot of effort is being expended on developing spatiotemporally-controlled drug delivery systems. Polymers and soft materials are at the core of such systems.
In my current project, I am focusing on cancer immunotherapy. Immunotherapy refers to treatments which harness and enhance the innate immune system to fight cancer. Over the years, several different approaches such as stimulating the effector mechanisms and suppressing the inhibitory mechanisms of the immune system have been developed as effective anti-cancer treatments.
Read More: A new dimension in cancer treatment
No comments:
Post a Comment